[#item_full_content] Q4 and FY2026 saw double-digit revenue growth in key cannabis segments, improved adjusted EBITDA, and a strengthened cash position following strategic recapitalization and the MTL Cannabis acquisition. FY2027 guidance targets positive adjusted EBITDA and further margin improvements.Original documen…  Read More